Raf kinases play an integral role in the classic MAP kinase (Raf/MERK/ERK) intracellular signaling cascade, but their role in specific developmental processes is largely unknown. Using a genetic approach, we have identified a role for B-Raf during hematopoietic progenitor cell development and during megakaryocytopoiesis. Fetal liver and in vitro ES cell-derived myeloid progenitor development is quantitatively impaired in the absence of B-Raf. Biochemical data suggest that this phenotype is due to the loss of a normally occurring rise in B-Raf expression and associated ERK1/2 activation during hematopoietic progenitor cell formation. However, the presence of B-raf -/-ES cellderived myeloid progenitors in the bone marrow of adult chimeric mice indicates the lack of an obligate cell-autonomous requirement for B-Raf in myeloid progenitor development.
INTRODUCTION
Cytokines play critical roles during hematopoietic development. 1 Some, such as stem cell factor (SCF), regulate early hematopoiesis through their action on multi-potent progenitors. 1 Others, such as erythropoietin (EPO), regulate later stages of hematopoiesis through their effects on specific, lineage-committed cells. 1 Thrombopoietin (Tpo), while first identified as a key cytokine regulator of megakaryocyte-lineage development, 2-5 also plays a vital role in hematopoietic progenitor or stem cell biology. 6, 7 Cytokine effects are mediated by the activation of specific intracellular signaling pathways following binding to their cognate receptors.
While the intracellular signaling pathways activated by most hematopoietic cytokines have been identified, their biological significance remains poorly understood.
The classic MAP kinase (Raf/MEK/ERK) intracellular pathway can affect cell proliferation, apoptosis, and differentiation in various cell lines and systems, 8, 9 yet its role in hematopoiesis remains undefined. Moreover, since the MAP kinase cascade is activated by various cytokines, one would predict that its function is context dependent.
As an entry point to the classic MAP kinase pathway, Raf kinases play a key role in controlling the signal flow from activated cytokine receptors by activating MAPK/ERK kinase 1/2 (MEK 1/2), which in turn activates ERK 1/2, the pathway's key known effector. 10 There are three known vertebrate Raf isoforms, A-Raf, B-Raf and Raf-1. 11 We recently reported that Raf-1 is not required for establishment of the myeloid progenitor compartment in murine bone marrow, megakaryocytopoiesis, or Tpo-induced ERK phosphorylation. 12 As the Raf/MEK/ERK pathway is activated by a number of cytokines, including Tpo, and our Raf-1 findings raised questions about previously
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While Raf-1 is the most studied Raf family member, B-Raf is more widely expressed than originally thought and is possibly the most potent MEK/ERK activator among the Raf isoforms. 11, 14 Recent reports suggest an important role for B-Raf in a number of pathologic and physiologic events including melanoma, thyroid, ovarian, and colon cancer, 15 sensory and motor neuron survival, 16 and mid-gestational mouse embryogenesis. [17] [18] [19] Moreover, the classic MAP kinase cascade is frequently activated in leukemia. This is most often due to Ras activating mutations, 20 but primary B-raf mutations have been identified in acute leukemias and malignant lymphomas. [21] [22] [23] Despite the important role of Ras activating mutations in hematopoietic pathology, and the recent entry of Raf inhibitors into clinical trails, [24] [25] [26] the role of B-Raf in hematopoiesis remains undefined.
In this study, we characterized the role of B-Raf in myelopoiesis using B-raf 
MATERIALS AND METHODS
Mice and genotyping. The generation of B-raf +/-mice was previously described. 19 The mice were backcrossed one generation to an MF1 background, and cells/well onto a fresh OP9 layer in the same culture medium supplemented with or without 50 ng/ml hTPO. Hematopoietic clusters were counted under a microscope after an additional three days of culture (i.e., 8 days total), The following day, after 9 total days of culture, loosely adherent and non-adherent cells were either re-seeded onto a new OP9 layer or used in methylcellulose colony-forming assays. After the day-9 re-plating, viable non-adherent cell number was determined using a trypan blue dye exclusion assay. Nonadherent cells were also cytospun for May-Giemsa staining, and differential counts were performed on 100 cells in each of three or more representative visual fields.
Cell surface marker and DNA ploidy analysis. For fetal liver cell surface marker analysis, freshly isolated fetal liver cells were incubated with PE-TER119 or FITC-CD45 Immunoblotting. Undifferentiated ES cells were collected after 75 min settling to deplete adherent feeder cells, and starved in serum-free -MEM medium for 3 hours.
Cells were then stimulated with 20% FCS for 0 to 60 min. Differentiating ES cells on day 5 of co-culture were collected after 60 min settling to deplete adherent OP9 cells, starved in serum-free -MEM medium for 3 hours, and then stimulated with 20% FCS for 0 to 60 min. Protein lysates were generated and Western blots performed essentially as described. 12 For quantification for ERK phosphorylation, the immunoblots were visualized by chemiluminescence and the images detected on X-ray films were quantified using NIH image software.
Statistics.
Comparison between any two groups was performed by unpaired student t test for normally distributed data or alternate Welch t test for non-normally distributed data.
RESULTS

Impaired fetal hematopoiesis in the absence of B-Raf. B-raf
-/-mice on a C57BL/6 background die in utero at day E9.5 -E11.5 with endothelial cell apoptosis and vascular leakage, precluding an opportunity to study fetal or adult hematopoiesis. 19 To extend their survival, the C57BL/6 B-raf +/-mice were crossed one generation onto the outbred MF1 background. Interbreeding of the mixed background B-raf +/-mice generated B-raf -/-fetuses that live until day E14.5 with a normal Mendelian distribution, allowing us to obtain fetal liver tissue for hematopoiesis studies. The B-raf -/-fetuses were smaller than their littermates and manifested a bleeding tendency similar to that previously described on a C57BL/6 background, 19 but it was delayed a few days.
Pregnant females from timed B-raf +/-x B-raf +/-matings were sacrificed at day E12.5, E13.5 and E14.5 of gestation to assess fetal hematopoiesis. No gross differences
were seen between heterozygous (B-raf
) and wild type (B-raf
only 85% of B-raf -/-embryos contained an identifiable liver under the dissecting microscope at day E12.5, which declined to 45% by day E14.5 ( Fig 1A) . Moreover, the The above findings turned our attention to the myeloid progenitor pool. Using methylcellulose colony assays, we found that the total number of myeloid progenitor cells was decreased in the B-raf -/-fetal livers (Fig. 1F, left panel) . However, the relative progenitor frequency as a fraction of the total number of fetal liver cells was not affected by the absence of B-Raf (Fig. 1F, right (Fig. 2B) .
Moreover, the number of myeloid progenitor cells generated is significantly (Fig. 2E) . In contrast, basal ERK1/2 phosphorylation in B-raf -/-day-5 mesodermal cells was significantly decreased, by nearly 90%, compared to wild-type cells (Fig 2F) . A similar loss of baseline activation is not seen for p38, a different MAP kinase family member that is not thought to be downstream of B-Raf (Fig. 2F ). In contrast with baseline activity, ERK1/2 phosphorylation following acute serum stimulation of B-raf -/-day-5 mesodermal cells
was not statistically significantly affected, averaging 80% (range = 45-108%; n = 4) that of wild-type cells (Fig 2F) . Of note, the absolute differences in ERK phosphorylation at baseline and maximal stimulation are similar, suggesting that B-Raf is normally active at both time points, and that its activity is at most minimally modified by the serum stimulation. The B-Raf expression kinetics (Fig. 2D ) and the basal ERK activity in day-5 mesodermal cells (Fig. 2F) correlate well with the quantitative defect in hematopoietic progenitor cell formation (Fig. 2C) . (Fig. 3C) 3C ), and its absence has little effect on the total number of hematopoietic cells obtained after 9 days of culture ( Fig. 4A) (Fig. 4D ). (Fig. 2) . Biochemical data suggest that this phenotype is due to the loss of a normally occurring rise in B-Raf expression and its associated rise in basal ERK1/2 activation (Fig.   2 ). However, the presence of B-raf -/-pluripotent progenitors in adult chimeric mice (Table 1) demonstrates the lack of an obligate cell-autonomous requirement for B-Raf in definitive hematopoietic progenitor cell formation. Tpo is known to activate the classic MAP kinase pathway 36 and has physiological effects both in early (stem/progenitor cells) and late (megakaryocyte lineage) hematopoiesis. 37, 38 Tpo-stimulated expansion of ES cell-derived myeloid progenitor cells is not altered by the lack of B-Raf (Fig. 4A ), but
B-Raf and
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Myeloid development of B-raf -/-ES cells in vivo.
Tpo-induced expansion of the megakaryocyte lineage, and concomitant suppression of mast cell production, is abrogated in the absence of B-Raf (Fig. 4B) . The quantitative defect in megakaryocyte lineage expansion in vitro is consistent with our chimeric mice data that show reduced B-raf -/-genotype contribution in megakaryocytes relative to myeloid progenitors (Table 1 ).
The absence of B-Raf produces a quantitative defect in myeloid progenitor cells.
However, the diminished number of progenitor cells in B-raf -/-fetal livers is not simply due to reduced replication or increased apoptotic cell death within the liver (Figs. 1D &   1E ), two biological functions often associated with Raf family members. 9, 31 In aggregate, these data suggest that B-Raf plays a critical role in establishing the proper number of (Fig 2F) , a developmental time point that appears critical for establishing the proper number of hematopoietic progenitor cells, and where (Figs. 2B -2D) . However, the B-Raf contribution to basal ERK 1/2 phosphorylation is developmental context dependent, being important in day-5 mesodermal colony cells but not in undifferentiated ES cells (Figs 2E & 2F) , which correlates with the developmental increase in B-Raf expression in the day-5 differentiated derivatives (Fig 2D) . Taken together, the data suggest that the loss of rising basal B-Raf activity, a reflection of increased B-Raf expression, underlies the quantitative defect in hematopoietic progenitor formation seen in the absence of BRaf. However, a mechanistically important kinase-independent role for B-Raf is also possible. Of note, others have also reported a key role for B-Raf in basal ERK activity using a B-raf -/-avian B cell line. 47 Moreover, using cells deleted for the raf-1 and/or Braf genes, they found that B-Raf is responsible for baseline MAP kinase signaling activity while B-Raf and Raf-1 contribute to ERK 1/2 phosphorylation following acute stimulation. 47 Our data also suggest that during hematopoiesis different Raf isoforms play different roles in ERK 1/2 activation at baseline and following stimulation (Fig 2F) .
B-Raf expression is normally up-regulated
Genetic studies using cells lacking both Raf-1 and B-Raf should further our understanding of the role of Raf isoforms in MAP kinase activation during hematopoiesis.
In addition to its effect on hematopoietic progenitor development, the absence of B-Raf also affected megakaryocytopoiesis. Wild-type and B-raf -/-ES cells co-cultured with OP9 cells without added cytokines generate an identical mature cell differential after day 9 of culture ( Fig. 4B) . However, the Tpo-induced expansion of the megakaryocyte lineage, and the suppression of mast cell development observed with wild-type ES cells are abrogated by the absence of B-Raf (Fig. 4B) For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From
